Patients with splenic sequestration often present with sudden onset of symptoms. These may include:

• Rapid enlargement of the spleen (splenomegaly)
• Severe anemia, leading to fatigue and weakness
• Pallor (pale skin)
• Tachycardia (rapid heartbeat)
• Hypotension (low blood pressure)
• Abdominal pain, particularly in the left upper quadrant
• In severe cases, shock may occur due to the sudden loss of circulating blood volume.

The diagnostic workup for splenic sequestration involves:

• Physical Examination: Noting an enlarged spleen and signs of anemia.
• Blood Tests: Complete blood count (CBC) to assess hemoglobin levels and reticulocyte count, which indicates bone marrow response.
• Ultrasound: Imaging to confirm splenomegaly and rule out other causes of abdominal pain.
• Patient History: Understanding the patient's history of sickle cell disease or other hemolytic anemias.

Immediate treatment is crucial and may include:

• Blood Transfusion: To rapidly correct anemia and stabilize the patient.
• Intravenous Fluids: To maintain blood pressure and prevent shock.
• Splenectomy: Surgical removal of the spleen may be considered in recurrent cases to prevent future episodes.
• Monitoring: Close observation in a hospital setting to manage potential complications.

The prognosis for splenic sequestration varies:

• Acute Episodes: With prompt treatment, patients can recover from an acute episode.
• Recurrent Episodes: May lead to chronic complications and necessitate splenectomy.
• Long-term Outlook: Depends on the underlying condition, such as sickle cell disease, and the patient's overall health.

Splenic sequestration is primarily linked to:

• Sickle Cell Disease: Abnormal red blood cells get trapped in the spleen.
• Other Hemolytic Anemias: Conditions that cause red blood cells to break down prematurely.

• Prevalence: Most common in children with sickle cell disease, particularly those under five years old.
• Geographic Distribution: Higher incidence in regions where sickle cell disease is prevalent, such as sub-Saharan Africa, India, and the Middle East.

In splenic sequestration:

• Red Blood Cell Trapping: Abnormal or sickled red blood cells become trapped in the spleen.
• Splenic Enlargement: The spleen enlarges as it fills with trapped cells.
• Anemia: The sudden pooling of blood in the spleen reduces circulating blood volume, causing anemia.

Preventive strategies focus on managing the underlying condition:

• Regular Monitoring: Routine check-ups for patients with sickle cell disease.
• Hydroxyurea: Medication that can reduce the frequency of sickle cell crises.
• Education: Teaching patients and caregivers to recognize early signs of splenic sequestration.

Splenic sequestration is a serious complication of sickle cell disease characterized by the sudden enlargement of the spleen and severe anemia. Prompt recognition and treatment are essential to prevent life-threatening complications. Long-term management may involve preventive strategies and, in some cases, surgical intervention.

For patients and caregivers:

• Understand the Condition: Know that splenic sequestration is a risk for those with sickle cell disease.
• Recognize Symptoms: Be aware of signs like sudden fatigue, pallor, and abdominal pain.
• Seek Immediate Care: If symptoms occur, seek medical attention promptly.
• Follow Medical Advice: Adhere to treatment plans and attend regular check-ups to manage the underlying condition effectively.